NEW YORK, April 14 (GenomeWeb News) - Protein biochip developer Protagen has closed a first round of private-equity financing with the S-VentureCapital, the Dortmund, Germany-based company said today.
Details of the funding were not provided.
Registering provides access to this and other free content.
Already have an account?Login Now.
Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.
DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.
A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.
In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.